CD4 and cancer: A recently developed assay platform for measuring the activities of the most relevant signal transduction pathways was used to in vitro characterize the functional states of different subsets of CD4+ T cells with respect to the signaling pathway activity, identify the pathway profile of immunotolerant CD4+ T cells and analyze the immunosuppressive effect of the cancer tissue SN.